Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2020 Jun 22;18(6):e3000722. doi: 10.1371/journal.pbio.3000722

NCX1 represents an ionic Na+ sensing mechanism in macrophages

Patrick Neubert 1,#, Arne Homann 1,#, David Wendelborn 1,#, Anna-Lorena Bär 1, Luka Krampert 1, Maximilian Trum 2, Agnes Schröder 3, Stefan Ebner 1,4, Andrea Weichselbaum 1, Valentin Schatz 1, Peter Linz 5, Roland Veelken 6, Jonas Schulte-Schrepping 7, Anna C Aschenbrenner 7,8, Thomas Quast 9, Christian Kurts 10, Sabrina Geisberger 11,12, Karl Kunzelmann 13, Karin Hammer 2, Katrina J Binger 14, Jens Titze 15, Dominik N Müller 11,12, Waldemar Kolanus 9, Joachim L Schultze 7,16, Stefan Wagner 2, Jonathan Jantsch 1,*
Editor: Paula M Oliver17
PMCID: PMC7307728  PMID: 32569301

Abstract

Inflammation and infection can trigger local tissue Na+ accumulation. This Na+-rich environment boosts proinflammatory activation of monocyte/macrophage-like cells (MΦs) and their antimicrobial activity. Enhanced Na+-driven MΦ function requires the osmoprotective transcription factor nuclear factor of activated T cells 5 (NFAT5), which augments nitric oxide (NO) production and contributes to increased autophagy. However, the mechanism of Na+ sensing in MΦs remained unclear. High extracellular Na+ levels (high salt [HS]) trigger a substantial Na+ influx and Ca2+ loss. Here, we show that the Na+/Ca2+ exchanger 1 (NCX1, also known as solute carrier family 8 member A1 [SLC8A1]) plays a critical role in HS-triggered Na+ influx, concomitant Ca2+ efflux, and subsequent augmented NFAT5 accumulation. Moreover, interfering with NCX1 activity impairs HS-boosted inflammatory signaling, infection-triggered autolysosome formation, and subsequent antibacterial activity. Taken together, this demonstrates that NCX1 is able to sense Na+ and is required for amplifying inflammatory and antimicrobial MΦ responses upon HS exposure. Manipulating NCX1 offers a new strategy to regulate MΦ function.


Inflammation and infection can trigger local tissue accumulation of sodium ions, boosting pro-inflammatory antimicrobial activity of monocyte/macrophage-like cells. This study shows that the sensing of sodium ions by macrophages requires the sodium/calcium exchanger NCX1.

Introduction

Infection and inflammation can trigger localized accumulation of sodium (Na+) in skin [13]. This accumulation is similar to that induced by high-Na+–containing diets and increases the effective osmolyte concentration within the skin to more than 40 mM above that of normal, isotonic blood [1,4].

Although blood Na+ is tightly regulated by the kidney, it has been established that monocyte/macrophage-like cells (MΦs) are necessary for the clearance of skin electrolytes upon dietary high-salt (HS) challenges [4,5]. However, the precise molecular mechanisms that orchestrate Na+ accumulation in the skin remain elusive, clearance by MΦs requires the osmoprotective transcription factor nuclear factor of activated T cells 5 (NFAT5) [4,6], which is the calcineurin-independent member of the NFAT family (reviewed in [7,8]).

In addition to regulating skin Na+ levels, the response of MΦs to infection and/or inflammation is modulated by increased local Na+ levels. Increases in Na+ limit anti-inflammatory regulatory MΦ activation while amplifying proinflammatory and antimicrobial activity [1,915]. We have shown that high Na+ increases NFAT5-dependent nitric oxide synthase 2 (Nos2) expression in lipopolysaccharide (LPS)-activated MΦs, resulting in increased antimicrobial nitric oxide (NO) production. High-Na+ conditions also enhanced autolysosome formation of infected MΦs, which together with increased NO, ultimately facilitates increased antimicrobial responses [1,10]. Although these findings established that alterations in local Na+ influence MΦ biology, the initial molecular responses of MΦs to high-Na+ environments remain unclear.

Here, we demonstrate that exposure to high extracellular Na+ stimulates the MΦ Na+/Ca2+ exchanger 1 (NCX1, also known as solute carrier family 8 member A1 [SLC8A1]), resulting in Na+ influx and Ca2+ efflux. We show that these NCX1-dependent currents are required for Na+-increased proinflammatory MΦ activity. Altogether, this study identifies a new molecule important for MΦs to sense increases in local Na+ levels and regulate their biology.

Results

Elevated extracellular Na+ triggers Na+ influx into MΦs

The elevated levels of extracellular skin Na+ can be mimicked in vitro by the addition of 40 mM NaCl to standard cell culture media [1,4,10,11]. We exposed MΦs to increased extracellular Na+ (+40 mM NaCl; +80 mOsm/kg; HS). Chemical analysis of Na+ content revealed that HS substantially increased cellular Na+ levels compared with normal salt (NS) in an LPS-independent manner (Fig 1A). To monitor intracellular Na+ in situ ([Na+]i), we used MΦs loaded with the Na+-sensitive dye sodium-binding benzofuran isophthalate (SBFI). LPS stimulation alone did not alter [Na+]i. HS exposure, however, resulted in an immediate increase in [Na+]i in the absence or presence of LPS (Fig 1B). Of note, the osmolality control urea did not trigger substantial Na+ entry into MΦs (Fig 1C).

Fig 1. HS conditions induce rapid Na+ influx in MΦs.

Fig 1

(A) Total Na+ content of RAW264.7 MΦs ± 10 ng/ml LPS under NS or HS (NS + 40 mM NaCl) conditions (mean ± SD; n = 11–12; Student t test ± Welch correction; *p < 0.05). (B) Relative [Na+]i of RAW264.7 MΦs. Traces of RAW264.7 MΦs stimulated with HS, LPS, or both at t = 10 s (mean ± SD; n = 7–9). (C) Relative [Na+]i of RAW264.7 MΦs. Traces of RAW264.7 MΦs stimulated with HS or 80 mM urea at t = 10 s (mean ± SD; n = 5). For numerical raw data, please see S1 Data. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; [Na+]i, intracellular Na+ in situ; NS, normal salt.

We hypothesized that one (or more) proteins at the plasma membrane might mediate HS-triggered Na+ influx. A query in the ImmGen database [16] revealed that mouse MΦs express transcripts for several ion channels, exchangers, and transporters, which are able to facilitate Na+ entry. This list includes the epithelial Na+ channel 1 alpha subunit, Na+/H+ antiporter, the voltage-gated Na+ channel, acid-sensing ion channels, Na+-K+-Cl symporter, and NCX1 (Slc8a1). In addition, HS-triggered signaling might also depend on transient receptor potential cation channel subfamily V member 4 (TRPV4). To measure whether Na+ influx by one of these molecules is involved in HS-boosted inflammatory (i.e., LPS-induced) MΦ activation, we used selective inhibitors targeting these molecules (S1 Table) and quantified NO production. Because HS alone (in the absence of LPS) does not induce NO production (Fig 2), as described earlier [1,10], we used MΦs stimulated with LPS in the presence of HS for this screening purpose (Fig 2). Conforming to our earlier findings [1,10], HS increased LPS-triggered NO release, whereas the osmolality control urea did not (Fig 2). The various inhibitors (S1 Table) revealed that only exposure to the NCX inhibitors KB-R7943 mesylate (KB-R) [17], SEA 0400 (SEA) [18], and NiCl2 [19] impaired HS-increased NO production in LPS-stimulated MΦs (Fig 2). Of note, these NCX inhibitors did not trigger NO production in the absence of LPS (S1 Fig).

Fig 2. NCX inhibitors abrogate HS-boosted NO production of LPS-stimulated MΦs.

Fig 2

Lower panel: nitrite levels of RAW264.7 MΦs pretreated with indicated inhibitors and stimulated ± LPS ± HS or 80 mM urea (mean ± SD; n = 9; Student t test or Mann–Whitney test; *p < 0.05). Upper panel: changes of means in nitrite production upon indicated stimulation and/or treatment (Δ nitrite). For numerical raw data, please see S1 Data. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; NO, nitric oxide; NS, normal salt; n.s., not significant.

MΦs are known to express NCX [20], of which NCX1 and NCX3 are expressed in human MΦs [21]. A query of the ImmGen database [16] revealed that NCX1 (Scl8a1) is robustly expressed in mouse MΦs, whereas there was minimal expression of Scl8a2 (the gene coding for NCX2) and Scl8a3 (NCX3). These findings were confirmed by quantitative real-time PCR (qRT-PCR) analysis of mouse MΦs (Fig 3A). There are several Slc8a1 splice variants known (reviewed in [22]). To determine the dominantly expressed variant (Fig 3B), we analyzed RNA sequencing (RNA-seq) data of bone marrow–derived MΦs (BMDMs). Transcriptome assembly identified two additional transcript variants (Fig 3B, red). Transcript abundance estimation revealed dominant expression of one novel variant (StringTie Assembly version 1), which skipped an internal exon and featured an additional 5′ exon upstream of the open reading frame (ORF), representing an alternative untranslated region (UTR). This novel Slc8a1 variant has not been annotated in the standard GENCODE version M10 or RefSeq catalog, but it has been independently predicted by the National Center for Biotechnology Information (NCBI) eukaryotic gene prediction tool Gnomon under XM_006523944 (Fig 3B, blue).

Fig 3. MΦs express a novel Slc8a1 splice variant.

Fig 3

(A) A representative real-time amplification plot of Slc8a1, Slc8a2, and Slc8a3 in BMDMs, RAW264.7 MΦs, and brain tissue out of two experiments. (B) Shown are the alignments of RNA-seq reads of BMDMs and their coverage with annotated (gray; GENCODE: ENSMUST00000086538.9, ENSMUST00000163123.1, ENSMUST00000163680.8), predicted (blue; RefSeq PREDICTED: XM_006523944), and StringTie-assembled (red; StringTie Assembly version 1, StringTie Assembly version 2) Slc8a1 splice variants. For numerical raw data, please see S1 Data. The RNA-seq data can be found in the GEO database (https://www.ncbi.nlm.nih.gov) under accession number GSE136662. BMDM, bone marrow–derived MΦ; GEO, Gene Expression Omnibus; MΦ, monocyte/macrophage-like cell; RNA-seq, RNA sequencing; Slc8, solute carrier family 8.

Increases in extracellular Na+ stimulate MΦ NCX currents

To explore the functional role of NCX in HS-increased inflammatory MΦ activation, we assessed whole-cell currents (whole-cell voltage clamp) of MΦ as a function of the membrane potential (Vm). The HS-sensitive current, determined as the difference between the current in the presence and absence of HS, showed increased inward currents (Fig 4A, left panel), suggesting influx of positively charged ions upon HS exposure. As published earlier [23,24], we found that the LPS-sensitive current, determined as the difference between the current in the presence and absence of LPS, showed outward rectification at positive Vm (Fig 4A, middle panel). By contrast, exposure of MΦ to LPS in the presence of HS reduced outward currents and increased inward currents (Fig 4A, right panel). Overall, this is consistent with HS triggering the influx of positively charged ions at negative Vm and reduced net efflux at positive Vm. In a separate set of experiments, we used NiCl2 to block NCX currents rapidly. NiCl2 pretreatment abolished HS-triggered inward currents (Fig 4B, left panel). However, NiCl2 treatment prior to LPS stimulation did not affect the outward rectification of the LPS-sensitive currents at positive Vm (Fig 4B, middle panel). Again, NiCl2 treatment prior to stimulation with LPS and HS abrogated HS-triggered increased inward currents but did not affect the LPS-sensitive currents at positive Vm (Fig 4B, right panel).

Fig 4. HS exposure results in NCX-mediated inward currents.

Fig 4

(A) Current/voltage relationships of MΦ ± LPS ± HS. Whole-cell VC experiments were performed before and after stimulation of BMDMs. Voltage steps were applied, and differential currents (IHS, ILPS, ILPS+HS) were plotted (mean ± 95% CI; n = 10–13). (B) As in (A), but with NiCl2 pretreatment (means ± 95% CI; n = 10). (C) Current/voltage relationships of BMDMs stimulated with LPS ± HS followed by NiCl2 treatment. Whole-cell VR experiments were performed, and Ni-sensitive (i.e., NCX-sensitive) currents (INCX) were determined (means ± 95% CI; n = 9). (D) ErevNCX (means ± SD; n = 9; Mann–Whitney test; *p < 0.05). (E) Resting Vm of BMDMs (means ± SD; n = 36). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; ErevNCX, NCX reversal potential; HS, high salt; I, current; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; VC, voltage clamp; Vm, membrane potential; VR, voltage ramp.

In order to analyze NCX currents directly, we measured the total current of LPS- and LPS + HS–treated MΦs before and after addition of NiCl2. The Ni-sensitive current, determined as the difference between the current in the absence and presence of NiCl2, was used as a direct measure of NCX current. Compared with LPS alone, at Vm values negative from the NCX reversal potential (Erev), additional HS exposure enhanced NCX inward current (Fig 4C). Altogether, this suggests that NCX mediates Na+ entry. Moreover, HS exposure shifted the ErevNCX from −20.9 mV to −7.6 mV, consistent with the increased electrochemical gradient for Na+ ions upon HS (Fig 4D).

Since the forward mode of the NCX exchange activity can only occur at Vm negative of Erev [25], we measured the resting Vm in untreated and LPS-stimulated MΦs by whole-cell patch clamp technique (current clamp). In line with earlier publications [2630], we detected a Vm of −18.7 mV in resting MΦs (Fig 4E), which did not significantly change upon LPS stimulation (S2 Fig). Under NS and LPS conditions, this resting Vm is very close to the ErevNCX. This incapacitates NCX-mediated currents to occur in LPS-treated MΦs under NS conditions; however, with HS exposure, it shifts the Erev into positive directions (Fig 4D), generating the driving force for forward-mode NCX inward currents to occur.

Increases in extracellular Na+ result in Ca2+ loss

In its forward mode, NCX not only allows for Na+ entry but extrudes Ca2+ in exchange (reviewed in [22,31]). Accordingly, we hypothesized that a rapid efflux of Ca2+ from MΦs may accompany the HS-triggered increase in [Na+]i. Therefore, we analyzed the emitted fluorescence of Fura-2–loaded MΦs as a measure of intracellular Ca2+ in situ ([Ca2+]i) (Fig 5A and 5B). In accordance with previous publications [3234], there was no long-lasting increase in [Ca2+]i upon LPS stimulation under NS in MΦs (Fig 5B). Exposure to HS in the absence or presence of LPS stimulation, however, resulted in a rapid decrease of [Ca2+]i (Fig 5A and 5B). We confirmed these results using flow cytometry–based analysis after staining with the Ca2+-sensitive dyes Fluo-3 and Fura-Red. Again, upon HS exposure in the absence of presence of LPS, we noted a rapid decrease of [Ca2+]i, which inversely mirrored the increase of [Na+]i (Fig 5C and 5D). This further supports the notion that a single exchange mechanism may contribute to HS-triggered Na+ influx and Ca2+ loss in MΦs.

Fig 5. HS exposure causes Ca2+ loss.

Fig 5

(A) Relative [Ca2+]i levels of RAW264.7 MΦs. Traces of Fura-2–loaded RAW264.7 MΦs stimulated ± HS at t = 10 s (mean ± SD; n = 6). Where indicated, Tg was added (means ± SD; n = 2). (B) As in (A), but RAW264.7 MΦs were stimulated with LPS ± HS at t = 10 s (mean ± SD; n = 5). Where indicated, Tg was added (means ± SD; n = 2). (C) As in (A), but relative [Ca2+]i levels were assessed in Fluo-3/Fura-Red–loaded MΦs (means ± SD; n = 6). (D) As in (B), but relative [Ca2+]i levels were assessed in Fluo-3/Fura-Red–loaded MΦs (means ± SD; n = 8). For numerical raw data, please see S1 Data. [Ca2+]i, intracellular Ca2+ in situ; HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; Tg, thapsigargin.

To assess whether HS-dependent decreases in [Ca2+]i were mediated by increased uptake into intracellular stores, we exposed MΦs to thapsigargin (Tg, an inhibitor of the endoplasmic reticulum Ca2+-ATPase; reviewed in [35]) at the end of the experiments. Tg treatment resulted in a transient release of Ca2+ from intracellular stores, leading to an increase in [Ca2+]i (Fig 5A, 5B, 5C and 5D). Importantly, HS exposure did not abolish the Tg-dependent Ca2+ release, suggesting that changes in Ca2+ uptake into intracellular stores upon HS exposure are not involved.

Pharmacological inhibition of NCX interferes with HS-boosted MΦ function

To further corroborate these findings, we used KB-R at a concentration known to inhibit the NCX forward mode (reviewed in [36]) and measured the HS-dependent changes in [Na+]i and [Ca2+]i in the absence or presence of LPS. KB-R treatment did not impair MΦ viability (S3 Fig) but blunted HS-triggered Na+ entry in the absence or presence of LPS (Fig 6A and 6B). This was paralleled by abrogated HS-mediated changes in [Ca2+]i (Fig 6C and 6D).

Fig 6. Pharmacological inhibition of NCX activity blunts HS-triggered Na+ influx and Ca2+ loss.

Fig 6

(A) Relative [Na+]i levels in RAW264.7 MΦs. Traces of RAW264.7 MΦs stimulated ± HS (at t = 10 s) ± KB-R pretreatment (means ± SD; n = 4–8). (B) Relative [Na+]i levels in RAW264.7 MΦs. Traces of RAW264.7 MΦs stimulated with LPS ± HS (at t = 10 s) ± KB-R pretreatment (means ± SD; n = 5–8). (C) As in (A), but relative [Ca2+]i levels were assessed in Fura-2–loaded MΦs (means ± SD; n = 5–8). (D) As in (B), but relative [Ca2+]i levels were assessed in Fura-2–loaded MΦs (means ± SD; n = 6–8). For numerical raw data, please see S1 Data. [Ca2+]i, intracellular Ca2+ in situ; HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; KB-R, KB-R7943 mesylate; [Na+]i, intracellular Na+ in situ; NCX, Na+/Ca2+ exchanger.

Importantly, KB-R treatment interfered with HS-induced NFAT5 expression in the absence (S4A Fig) or presence of LPS stimulation (Fig 7A). In LPS-treated MΦs, this was paralleled by suppression of HS-boosted expression of the Nfat5 target gene Nos2 (Fig 7B), which is in line with the reduced effect of HS on LPS-induced NO production. (Fig 2). We additionally used NiCl2 and SEA to interfere with NCX activity. Again, these inhibitors did not affect MΦ viability (S3 Fig). NiCl2 treatment diminished HS-induced NFAT5 in the absence (S4B Fig) or presence of LPS (Fig 7C). NiCl2 abolished HS-augmented expression of Nos2 in LPS-stimulated MΦs (Fig 7D). Likewise, SEA interfered with HS-induced NFAT5 levels in the absence (S4C Fig) or presence of LPS (Fig 7E) and subsequently boosted Nos2 expression (Fig 7F).

Fig 7. Pharmacological inhibition of NCX activity blocks HS-boosted MΦ activity.

Fig 7

(A) Immunoblotting and densitometry of NFAT5 6 h after LPS ± HS in RAW264.7 MΦs ± KB-R pretreatment (n = 3; paired t test; *p < 0.05). (B) Nos2 levels in RAW264.7 MΦs 4 h after LPS ± HS ± KB-R pretreatment (means ± SD; n = 10; Student t test; *p < 0.05). (C) Immunoblotting and densitometry of NFAT5 in RAW264.7 MΦs 4 h after LPS ± HS ± NiCl2 pretreatment (n = 4; paired t tests; *p < 0.05). (D) Nos2 levels in RAW264.7 MΦs 4 h after LPS ± HS ± NiCl2 pretreatment (means ± SD; n = 6; Student t test + Welch correction; *p < 0.05). (E) Immunoblotting and densitometry of NFAT5 in RAW264.7 MΦs 4 h after LPS ± HS ± SEA pretreatment (n = 5; paired t test; *p < 0.05). (F) Nos2 in RAW264.7 MΦs 4 h after LPS ± HS ± SEA pretreatment (means ± SD; n = 10–12; Mann–Whitney test; *p < 0.05). (G) RFP-GFP-mLC3 RAW264.7 MΦs were infected with Escherichia coli ± HS ± SEA pretreatment. Representative images 2 h after infection (RFP: red; GFP: green; scale bar: 10 μm). (H) Relative E. coli load at 2 h after infection of RAW264.7 MΦs ± HS ± SEA pretreatment (means ± SD; n = 12; Student t tests; *p < 0.05). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. CFU, colony forming unit; GFP, green fluorescent protein; HS, high salt; KB-R, KB-R7943 mesylate; LPS, lipopolysaccharide; mLC3, microtubule-associated protein 1 light chain 3; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; NFAT5, nuclear factor of activated T cells 5; Nos2, nitric oxide synthase 2; NS, normal salt; n.s., not significant; RFP, red fluorescent protein; SEA, SEA 0400.

In addition to increasing Nos2 expression, HS-induced Nfat5 expression facilitates autolysosome formation upon infection, which is critically required for HS-boosted antibacterial activity directed against E. coli [10]. To test the impact of NCX inhibition on autolysosome formation, we used SEA in MΦs that express the tandem monomeric red fluorescent protein (RFP)-green fluorescent protein (GFP)–tagged microtubule-associated protein 1 light chain 3 (mLC3). Because GFP fluorescence is pH sensitive, GFP+RFP+ vesicles indicate autophagosomes, whereas GFPRFP+ vacuoles mark degradative, acidified autolysosomes [37]. In accordance with our previous findings [10], HS exposure boosted the formation of autolysosomes in controls; however, in NCX-inhibited cells, HS failed to increase autolysosome formation, indicating disturbed autophagy (Fig 7G). Building on our earlier findings that HS-boosted antibacterial activity hinges on increased autophagy [10], NCX inhibition incapacitated the effect of HS on antibacterial activity (Fig 7H).

Silencing of Slc8a1 abrogates HS-amplified MΦ function

Next, we used RNA interference (RNAi) to target NCX1 expression in MΦs. Transfer of Slc8a1-specific small interfering RNA (siRNA) reduced Slc8a1 mRNA levels in the absence (S5 Fig) and presence of LPS (Fig 8A). This was paralleled by diminished membranous expression of NCX1 (Fig 8B). Analysis of Ni-sensitive currents in Slc8a1-silenced MΦs upon HS exposure revealed that targeting Slc8a1 diminished Ni-sensitive inward currents (S6 Fig). Because Ni-sensitive currents represent NCX currents, this suggests that silencing of Slc8a1 is functional. Conforming to our pharmacological inhibitor data (Fig 6), silencing of Slc8a1 strongly reduced HS-triggered increase in [Na+]i (Fig 8C). Consistently, in this situation, HS failed to lower [Ca2+]i (Fig 8D).

Fig 8. Slc8a1 silencing decreases Na+ influx and Ca2+ efflux.

Fig 8

(A) Slc8a1 and (B) membranous NCX1 expression in LPS-stimulated ns or Slc8a1-specific siRNA–treated BMDMs after 4 h (means ± SD; n = 8; Mann–Whitney test; *p < 0.05). (C) Relative [Na+]i levels of ns siRNA and Slc8a1 siRNA–treated BMDMs exposed to LPS ± HS at t = 10 s (means ± SD; n = 5–7). (D) Relative [Ca2+]i levels in ns siRNA and Slc8a1 siRNA–treated BMDMs exposed to LPS ± HS at t = 10 s (means ± SD; n = 6–11). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. BMDM, bone marrow–derived MΦ; [Ca2+]i, intracellular Ca2+ in situ; HS, high salt; LPS, lipopolysaccharide; [Na+]i, intracellular Na+ in situ; ns, nonsilencing; NCX, Na+/Ca2+ exchanger; siRNA, small interfering RNA; Slc8, solute carrier family 8.

In line with this, Slc8a1-specific siRNA largely diminished the effect of Na+-induced NFAT5 protein levels in the absence (S7A Fig) and presence of LPS (Fig 9A). Silencing of Slc8a1 under NS conditions did not induce NO production (S7B Fig). In LPS-activated MΦs, Slc8a1 silencing abolished HS-triggered increases in Nos2 mRNA expression (Fig 9B) and reduced HS-augmented NO production (Fig 9C). Finally, Slc8a1 silencing abrogated HS-boosted autolysosome formation (Fig 9D) and subsequent antimicrobial activity (Fig 9E).

Fig 9. Slc8a1 silencing abrogates HS-augmented MΦ activity.

Fig 9

(A) ns siRNA and Slc8a1 siRNA RAW264.7 were treated with LPS ± HS. Representative NFAT5 and ACTIN immunoblot 4 h after stimulation from two experiments. (B) As in (A), but Nos2 in BMDMs 4 h after LPS ± HS (means ± SD; n = 6; Mann–Whitney test; *p < 0.05). (C) As in (B), but Δ nitriteHS LPS-LPS after 24 h (means ± SD; n = 8; Student t test). (D) ns siRNA and Slc8a1 siRNA–treated RFP-GFP-mLC3 RAW264.7 MΦs were infected with E. coli ± HS. Representative images 2 h after infection from three experiments (RFP: red; GFP: green; scale bar: 10 μm). (E) ns siRNA and Slc8a1 siRNA–treated BMDMs were infected with E. coli ± HS. E. coli load at 2 h infection (means ± SD; n = 12; Student t tests; *p < 0.05). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. BMDM, bone marrow–derived MΦ; CFU, colony forming unit; GFP, green fluorescent protein; HS, high salt; LPS, lipopolysaccharide; mLC3, microtubule-associated protein 1 light chain 3; MΦ, monocyte/macrophage-like cell; NFAT5, nuclear factor of activated T cells 5; Nos2, nitric oxide synthase 2; NS, normal salt; ns, nonsilencing; n.s., not significant; RFP, red fluorescent protein; siRNA, small interfering RNA; Slc8, solute carrier family 8.

Overall, the RNAi experiments corroborate our pharmacological inhibition experiments and demonstrate that NCX1-dependent signaling is critical for HS-boosted inflammatory and antimicrobial response (Fig 10).

Fig 10. Graphical summary.

Fig 10

NCX1 is required for Na+ entry and Ca2+ loss upon exposure of MΦs to HS conditions. In LPS-stimulated MΦs, NCX1 is required for HS-boosted NFAT5 accumulation and NO production. Moreover, NCX1 is required for enhanced autolysosome formation and bacterial removal upon HS exposure. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; NFAT5, nuclear factor of activated T cells 5; NO, nitric oxide.

Discussion

In addition to organic chemical signals, the local ionic inorganic tissue microenvironment is now recognized as a novel regulator of immune cell function (reviewed in [3840]). We and others have demonstrated earlier that local Na+ imbalances are able to influence immune cell activation and to boost MΦ activation. HS amplification of MΦ activation hinges on signal molecules such as p38/mitogen-activated protein kinase, NFAT5, and mitochondrial reactive oxygen species (ROS) production, which play an important role in both adaption to osmotic stress and innate cell activation [12,4145]. However, upstream LPS-independent mechanisms linking increased external Na+ to altered MΦ activation remained unknown.

In the present study, we show that exposure of MΦs to HS resulted in an immediate rapid increase in intracellular Na+. We investigated several Na+ entry pathways on their impact on HS-dependent MΦ stimulation. In line with earlier findings [15], we did not detect a contribution of voltage-gated Na+ channels. Moreover, our data demonstrate that amiloride-sensitive Na+ channels are not involved in HS-boosted MΦs. The latter have been implicated in microglia/MΦ function (reviewed in [46]) and Na+ sensing of dendritic cells [47]. In contrast, we show here that in MΦs, NCX1 contributes to Na+ entry and subsequent signaling that ultimately results in increased MΦ antimicrobial function upon HS exposure.

The increase of external Na+ from 140 mM to approximately 180 mM appears to result in a relatively small increase in the electrochemical gradient for Na+ across the membrane. Our data suggest that the plasma membrane of MΦs displays a high permeability for Na+ ions. Because the ErevNCX of LPS-treated MΦs matched the Vm of resting and LPS-stimulated MΦs, NCX currents are incapacitated under NS conditions. By contrast, the small increase in the electrochemical Na+ gradient upon HS treatment shifts the ErevNCX approximately 10 mV in the positive direction. Altogether, this facilitates the forward-mode activity of NCX, ultimately allowing Na+ cellular entry in exchange for Ca2+ efflux. Concordantly, we found a decrease in intracellular Ca2+. Considering the reported stoichiometric ratio of 3:1 for Na+/Ca2+ exchange (reviewed in [22]), a net movement of positive charges into the cell should rapidly depolarize the Vm of MΦs. Increases in intracellular Na+ and decreases in intracellular Ca2+ would rapidly reduce the driving force for NCX and incapacitate NCX currents again.

In accordance with others [3234], we did not detect any long-lasting increases of [Ca2+]i in MΦs exposed to LPS under NS, indicating that MΦs do not require such increases for their proinflammatory activity. This is in stark contrast to other cells, such as T cells (reviewed in [48]). Westphalen and colleagues reported that Ca2+ entry in alveolar MΦs through connexin 43–dependent interconnections from alveolar epithelial cells suppresses the inflammatory capacity of these MΦs [49]. Moreover, increases in intracellular Ca2+ can trigger adenosine monophosphate–activated protein kinase activity, which is able to curtail inflammatory properties of mononuclear myeloid cells [50]. This indicates that high Ca2+ levels can exert anti-inflammatory MΦ activity, implying that, conversely, lowering Ca2+ might lead to increased proinflammatory activity. Following this reasoning, we show that lowering [Ca2+]i via NCX1 is linked to HS-boosted proinflammatory activation and antimicrobial MΦ function.

Moreover, low intracellular Ca2+ levels can induce autophagy (reviewed in [51]) where autophagy is regulated by numerous ion channels, exchangers, and transporters (reviewed in [52]). Previously, we found that the activation of autophagy represents an important auxiliary mechanism to boost antibacterial defense under HS conditions [10]. Here, we demonstrate that NCX1 plays an important role in this HS-boosted autophagy. Building on our earlier publication [10], our finding that interfering with NCX1 abolishes HS-increased autolysosomal formation provides a link between antibacterial responses and NCX1-dependent ion sensing. Our data show that extracellular Na+ is able to impact on intracellular organelle formation via NCX1. Very recently, it turned out that subcellular distribution of Na+ via two-pore channels plays an important role in controlling the volume of macropinosomes and, thereby, the cell size of MΦs [53]. Determining how increases in extracellular Na+ influence these subcellular processes requires further studies.

It is tempting to speculate that sensing of the ionic microenvironment represents a very ancient mechanism that allows animals to sense barrier dysfunction and consequently amplify antimicrobial and inflammatory MΦ responses. Here, we show that Na+ sensing by NCX1 represents an ionic mechanism important for MΦs to sense danger (Fig 10). The identification of this molecule opens new avenues to fine-tune MΦ immunobiology.

Material and methods

Ethics statement

Animal care and use followed the regulations of the German Animal Welfare Act. Mice were housed at Zentrale Tierlaboratorien (ZTL) der Universität Regensburg and kept under conditions approved by Umweltamt der Stadt Regensburg.

Reagents and antibodies

The stimulations were performed with LPS from Sigma-Aldrich (E. coli O111:B4; #2630) and NaCl from Merck (#1.06400.1000). The channel inhibitors were purchased from Tocris (KB-R7943 mesylate [#12144] [17], SEA0400 [#6164] [18], amiloride [#0890] [54], EIPA [#3378] [55], and GSK 2193874 [#5106] [56]), Biotrend (tetrodotoxin [#BN0518] [57] and furosemide [(#BG0201] [58]), Sigma-Aldrich (DAPI [#D8417-5MG] [59]), and AppliChem (NiCl2 [#A2199,1000] [19]). For western blotting, we used rabbit anti-NCX1 antibodies from Abcam (#ab151608), rabbit anti-NFAT5 antibodies from Thermo Fisher Scientific (#PA1-023), and rabbit anti-ACTIN antibodies from Sigma-Aldrich (#A2066). Swine anti-rabbit HRP (Dako; #p0399) was used as secondary antibody.

MΦ generation

We euthanized the mice before getting the marrow. BMDMs were generated in Teflon bags or Petri dishes supplemented with supernatant of L929 cells, as described earlier [60].

RNAi in MΦ

Prior to the experiments, we confirmed that commercially available siRNA binds to the predicted Slc8a1 transcript XM_006523944 using BLAST. We performed RNAi using Slc8a1 siRNA (Dharmacon; # L-044925-00-0005) as described earlier [61]. After electroporation, cells were incubated for 1 d before further treatment and analysis.

MΦ stimulation and infection experiments

MΦs were stimulated with LPS, resulting in a final concentration of 10 ng/ml LPS. NaCl (40 mM) or urea (80 mM) was added to MΦs where indicated. Both an increase of 40 mM in NaCl or adding of 80 mM urea increase osmolality by 80 mOsm/kg [1]. MΦ infection experiments were performed as described previously [1,10]. In brief, BMDMs or RAW264.7 MΦs were infected with E. coli HB101 (multiplicity of infection [MOI] of 100) for 1 h ± HS or SEA0400 (25 μM). MΦs were washed two times with PBS in order to remove remaining extracellular bacteria. Gentamicin (100 μg/ml) was added to the NS and HS conditions for an additional 1 h. Subsequently, cells were lysed with 0.1% Triton/0.05% Tween-20 in PBS. Bacterial solutions were serially diluted and plated on Müller–Hinton agar plates. The next day, colony forming units (CFUs) were manually counted and normalized to the mean of the untreated NS group.

Measurement of intracellular Na+ by atomic absorption spectrometry

In all, 2 × 106 RAW264.7 MΦs were stimulated with LPS ± HS for 10 min. Subsequently, cells were harvested and washed with iso-osmolal urea buffer. The MΦ pellet was lysed in 100 μl H2Odd containing 0.1% Triton X, and the Na+ content was determined by atomic absorption spectrometry (Perkin Elmer, model 3100).

Intracellular ion determination via epifluorescence microscopy

MΦs were seeded on FluoroDish plates. For Na+ and Ca2+ measurements, cells were stained as indicated with SBFI (Thermo Fisher Scientific; #S1264) or Fura-2 (Thermo Fisher Scientific; #F1221) in Tyrode solution (140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 5 mM HEPES, 1 mM CaCl2, 10 mM glucose) containing 0.04% Pluronic (Sigma; #P2443). Cells were subjected to ratiometric quantification of the respective fluophor via live cell imaging for 5–10 min (epifluorescence microscope Motic model 410E). After 10 sec, 40 mM NaCl ± LPS was added to the dish, or cells were left untreated. Fluorescence emissions were recorded, analyzed using IonWizard (IonOptix Cooperation) as described earlier [62], and normalized to the start value.

Intracellular Ca2+ measurements using flow cytometry

RAW264.7 MΦs were stained with the Ca2+-sensitive dyes Fluo-3 (Thermo Fisher Scientific; #F-1241) and Fura-Red (Thermo Fisher Scientific; #F-3021) [63] for 20 min at room temperature in Tyrode solution containing Pluronic. Subsequently, cells were washed and transferred into FACS tubes. Mean fluorescence intensities of Fluo-3 and Fura-Red were recorded over time using flow cytometry (FACSCanto II). After a lead-in phase of 2 min, HS ± LPS was added, or cells were left untreated. Samples were measured for an additional 5 min. Finally, Tg (Tocris; #1138) was added, and measurements were continued for 3 min. Recordings were analyzed via the “kinetics” tool of FlowJo (version 10). Fluo-3/Fura-Red ratios were calculated and normalized to the mean of the last three recordings before stimulation.

Whole-cell patch clamp experiments

For electrophysiological measurements, BMDMs were used, and medium was replaced by an extracellular bathing solution (EC) containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM glucose (pH 7.35) and kept at room temperature. The dishes were placed on the stage of an inverted microscope. Patch pipettes were pulled from filamented borosilicate glass capillaries showing resistances of 2–4.5 MΩ when filled with intracellular pipette solution (IC) containing 140 mM K-gluconate, 5 mM NaCl, 2 mM MgCl2, 1 mM CaCl2, 11 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP, and 0.3 mM Na-GTP (pH 7.35). The whole-cell configuration of the patch clamp technique [64] was used to record membrane currents and potential in voltage-clamp or current-clamp mode. Signals were recorded and digitized with an Axopatch 200B amplifier (Axon Instruments, Union City, CA) with a Digidata 1200 converter (Axon Instruments) or an EPC10 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). Analysis was performed using the software pCLAMP 10.2 (Axon Instruments) or PATCHMASTER 2x90 (HEKA).

Voltage steps were applied from a holding potential (−80 mV or −20 mV) from −100 mV to +80 mV in 10-mV increments and held for 200 ms. The voltage step protocol was performed 2 min after attaining the whole-cell configuration; afterward, cells were stimulated with 40 mM NaCl, 10 ng/ml LPS, or 5 mM NiCl2. At 3 min after stimulation, another voltage-clamp protocol was performed.

In a subset of experiments, a voltage ramp protocol from approximately −80 mV to approximately +80 mV (holding potential −20 mV, duration 4 sec, 40 mV/sec) was applied. Measured currents were normalized to the membrane capacitance. For Vm recordings, the cells were measured over 4 min in current-clamp-zero mode. After 50 sec, cells were stimulated. The first and last 50 sec of this recording were averaged to yield the Vm before and after stimulation.

For voltages between −40 mV and 30 mV, we fitted a straight line through the Ni-sensitive current data of LPS- and LPS + HS–treated MΦs using the nonlinear regression tool provided by GraphPad PRISM (version 6.0). We used the YIntercept and slope to determine ErevNCX.

Autophagy characterization

We seeded RFP-GFP-mLC3 RAW264.7 MΦs (obtained from Invivogen; rawdf-mlc3) on coverslips and infected them with MOI 100 of E. coli HB101 ± HS ± 30 min preincubation with SEA0400. At 1 h after infection, cells were washed twice with PBS and incubated in NS or HS media containing 100 μg/ml gentamicin. At 2 h after infection, cells were washed, fixed in 4% paraformaldehyde for 20 min at room temperature, and mounted with ProLong Gold (containing DAPI). A Leica TCS SP5 confocal laser microscope was used for imaging. Images were processed using the Leica Application Suite (version 2.7.3.9723) and Microsoft PowerPoint.

Bioinformatic analysis of Slc8a1 isoform expression

RNA of three murine BMDM samples differentiated in vitro for 8 d using M-CSF were isolated with Trizol and the miRNeasy micro kit (Qiagen) according to the manufacturer’s protocol. The quality of the RNA was assessed by visualization of 28S and 18S band integrity on a Tapestation 2200 (Agilent). In all, 100 ng of RNA was converted into cDNA libraries using the TruSeq RNA library preparation kit version 2. Size distribution of cDNA libraries was measured using the Agilent High Sensitivity DNA assay on a Tapestation 2200 (Agilent). cDNA libraries were quantified using KAPA Library Quantification Kits (Kapa Biosystems). After cluster generation on a cBot, 75-bp single-read sequencing was performed on a HiSeq1500.

For alignment and genome-guided transcriptome assembly, we followed the “new tuxedo” protocol [65]. After base calling and demultiplexing using CASAVA version 1.8.2, the 75-bp single-end reads were aligned to the mouse reference genome mm10 using HISAT2 version 2.0.6 with option–dta and sorted and indexed using Samtools version 0.1.19. Subsequently, transcriptome assembly was performed using StringTie version 1.3.2d, with default parameters for each of the three samples guided by GENCODE vM10 transcriptome annotation. Merging the individual assemblies using the StringTie–merge option produced two novel multiexon transcript variants for Slc8a1, labeled StringTie Assembly version 1 and version 2 (Fig 3B). Transcript abundances were estimated by rerunning StringTie with options -B -e and analyzed using the R package Ballgown [66]. The RNA-seq data were uploaded in the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov) under accession number GSE136662.

Quantification of nitrite and lactate dehydrogenase activity

Griess assays were used to quantify nitrite levels in the supernatants as described earlier [1,10]. The cell cytotoxicity kit (Roche; #11644793001) was used to measure lactate dehydrogenase (LDH) activities in supernatants and cell pellets. To assess the relative LDH release, the supernatant-to-pellet ratio of LDH activity was calculated.

Immunoblotting

For analysis of NFAT5 and ACTIN, MΦs were lysed in 8 M urea containing a protease inhibitor cocktail (Roche; #11836170001), and immunoblotting was performed as described earlier [1,10]. For analysis of NCX1, membranes of MΦs were isolated using the Mem-PER Plus Kit (Thermo Fisher Scientific; #89842Y) according to the manufacturer’s instructions, and immunoblotting for NCX1 was performed. Images were acquired on an Intas Chemostar chemoluminescence imager and processed using Adobe Photoshop CS6 and Microsoft PowerPoint. We used ImageJ (version 1.50b; Rasband, W. S., ImageJ, United States National Institutes of Health, https://imagej.nih.gov/ij/) for densitometry of western blots.

RNA isolation, reverse transcriptions, real-time PCR, and relative quantification

RNA isolation and qRT-PCR of cDNA was performed as described previously [10]. We obtained the following probes from Thermo Fisher Scientific for the analyses: Slc8a1 (Mm01232254_m1), Slc8a2 (Mm00455836_m1), Slc8a3 (Mm01309304_m1), Nos2 (Mm00440485_m1), and Hprt (Mm00446968_m1). Relative expression levels were determined using the ΔΔCT method. Hprt served as endogenous control.

Statistical analysis

All graphs were generated using GraphPad PRISM (version 6.0). Data sets were assessed for normality distribution via Kolomogorov–Smirnov tests. Normally distributed data were compared by unpaired, two-tailed Student t test (for two groups). We compared non-normally distributed data sets using Mann–Whitney tests (for two groups). In case of paired experiments (densitometry), we analyzed the data using paired Student t tests. Unless indicated otherwise, all data are depicted as means ± SD or 95% CI. We considered p-values < 0.05 as statistically significant.

Supporting information

S1 Table. Inhibitor data.

List of used inhibitors and concentrations.

(DOCX)

S1 Fig. Effects of NCX inhibitors on NO production.

NO production was quantified 24 h after incubation of RAW264.7 MΦs ± HS ± after pretreatment with indicated inhibitor. (A) Inhibitor KB-R (n = 9). (B) Inhibitor NiCl2 (n = 6). (C) Inhibitor SEA (n = 6). For numerical raw data, please see S1 Data. HS, high salt; MΦ, monocyte/macrophage-like cell; KB-R, KB-R7943 mesylate; NCX, Na+/Ca2+ exchanger; NO, nitric oxide; SEA, SEA 0400.

(TIF)

S2 Fig. Current clamp measurements of MΦ upon LPS stimulation.

Vm of BMDMs before and after addition of 10 ng/ml LPS (n = 8; paired t test; *p < 0.05). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; Vm, membrane potential.

(TIF)

S3 Fig. Effects on selected NCX inhibitors on MΦ viability.

RAW264.7 MΦs were pretreated with indicated NCX inhibitors. At 4 h after stimulation ± LPS ± HS relative LDH release normalized to total cellular LDH content was assessed. Exposure of cells to 0.1% Triton X was used as positive control for cytotoxicity (means ± SD; n = 9). For numerical raw data, please see S1 Data. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger.

(TIF)

S4 Fig. Effects of NCX inhibitors on NFAT5 accumulation.

(A) NFAT5 levels 6 h after incubation of RAW264.7 MΦs ± HS ± KB-R pretreatment. Immunoblotting and densitometry (n = 4; paired t tests; *p < 0.05). (B) NFAT5 levels 4 h after incubation of RAW264.7 MΦs ± HS ± NiCl2 pretreatment. Immunoblotting and densitometry (n = 4; paired t tests; *p < 0.05). (C) As in (B), but SEA was used to inhibit NCX (n = 7; paired t tests; *p < 0.05). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. HS, high salt; KB-R, KB-R7943 mesylate; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; NFAT5, nuclear factor of activated T cells 5; SEA, SEA 0400.

(TIF)

S5 Fig. Slc8a1 silencing reduces Slc8a1 mRNA levels.

Slc8a1 expression in ns or Slc8a1-specific siRNA–treated BMDMs (means ± SD; n = 8; Student t test; *p < 0.05). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8.

(TIF)

S6 Fig. Slc8a1 silencing diminishes inward currents upon HS treatment.

Current/voltage relationships of BMDMs treated with ns siRNA and Slc8a1 siRNA. These MΦ were stimulated with HS followed by NiCl2 treatment. Whole-cell VR experiments were performed, and Ni-sensitive (i.e., NCX-sensitive) currents were determined (means ± 95% CI; n = 9–10). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; HS, high salt; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8; VR, voltage ramp.

(TIF)

S7 Fig. Slc8a1 silencing reduces HS-augmented NFAT5 accumulation.

(A) NFAT5 expression 4 h after LPS ± HS in ns siRNA and Slc8a1 siRNA–treated RAW264.7 MΦs. Representative NFAT5 and ACTIN immunoblot out of two similar experiments. (B) As in (A), but HS-triggered Δ nitrite after 24 h (n = 3). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NFAT5, nuclear factor of activated T cells 5; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8.

(TIF)

S1 Data. Numerical raw data.

All numerical raw data are combined in a single Excel file “S1_Data.xlsx”. This file consists of several spreadsheets. Each spreadsheet contains the raw data of one subfigure.

(XLSX)

S1 Blots. Raw images.

The file “S1_Blots.pdf” covers all uncropped western blot images, including size standards and descriptions.

(PDF)

Acknowledgments

We are grateful to Monika Nowottny, Christine Lindner, Barbara Bodendorfer, and Dr. Roland Lang for help in generating macrophages.

Abbreviations

BMDM

bone marrow–derived MΦ

[Ca2+]i

intracellular Ca2+ in situ

Erev

reversal potential

GFP

green fluorescent protein

HS

high salt

KB-R

KB-R7943 mesylate

LPS

lipopolysaccharide

monocyte/macrophage-like cell

mLC3

microtubule-associated protein 1 light chain 3

[Na+]i

intracellular Na+ in situ

NCBI

National Center for Biotechnology Information

NCX

Na+/Ca2+ exchanger

NFAT5

nuclear factor of activated T cells 5

NO

nitric oxide

NS

normal salt

ns

nonsilencing

NOS2

nitric oxide synthase 2

ORF

open reading frame

qRT-PCR

quantitative real-time PCR

RFP

red fluorescent protein

RNAi

RNA interference

RNA-seq

RNA sequencing

ROS

reactive oxygen species

SBFI

sodium-binding benzofuran isophthalate

SEA

SEA 0400

siRNA

small interfering RNA

SLC8

solute carrier family 8

Tg

thapsigargin

TRPV4

transient receptor potential cation channel subfamily V member 4

UTR

untranslated region

Vm

membrane potential.

Data Availability

All relevant data are within the paper and its supporting information files (S1 Data, S1 Blots). The RNA-seq data was deposited in the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov). The accession number is GSE136662.

Funding Statement

JJ received funding from the DFG (JA1993/6-1) and DFG SFB 1350 grant (project nr. 387509280, TPB5). SW is funded by DFG grants WA 2539/4-1, 5-1, and 7-1, by a DFG SFB 1350 grant (project nr. 387509280, TPA6), and by the Deutsches Zentrum für Herz-Kreislauf-Forschung ([DZHK]; German Center for Cardiovascular Research). JJ, SW, and KH are supported by the ReForM C program of the Medical Faculty University of Regensburg. JLS received funding from the DFG under Germany’s Excellence Strategy – EXC2151 – 390873048 and the EU under project SYSCID (grant nr. 733100). DNM is supported by the DZHK and the DFG (SFB 1365). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Jantsch J, Schatz V, Friedrich D, Schroder A, Kopp C, Siegert I, et al. Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab. 2015;21(3):493–501. Epub 2015/03/05. 10.1016/j.cmet.2015.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Matthias J, Maul J, Noster R, Meinl H, Chao YY, Gerstenberg H, et al. Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment. Sci Transl Med. 2019;11(480). Epub 2019/02/23. 10.1126/scitranslmed.aau0683 . [DOI] [PubMed] [Google Scholar]
  • 3.Schwartz L, Guais A, Pooya M, Abolhassani M. Is inflammation a consequence of extracellular hyperosmolarity? J Inflamm (Lond). 2009;6:21 Epub 2009/06/25. 10.1186/1476-9255-6-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15(5):545–52. Epub 2009/05/05. 10.1038/nm.1960 . [DOI] [PubMed] [Google Scholar]
  • 5.Machnik A, Dahlmann A, Kopp C, Goss J, Wagner H, van Rooijen N, et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension. 2010;55(3):755–61. Epub 2010/02/10. 10.1161/HYPERTENSIONAHA.109.143339 . [DOI] [PubMed] [Google Scholar]
  • 6.Wiig H, Schroder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 2013;123(7):2803–15. Epub 2013/06/01. 10.1172/JCI60113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Aramburu J, Lopez-Rodriguez C. Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5. Front Immunol. 2019;10:535 Epub 2019/04/06. 10.3389/fimmu.2019.00535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Choi SY, Lee-Kwon W, Kwon HM. The evolving role of TonEBP as an immunometabolic stress protein. Nat Rev Nephrol. 2020. 10.1038/s41581-020-0261-1 . [DOI] [PubMed] [Google Scholar]
  • 9.Berry MR, Mathews RJ, Ferdinand JR, Jing C, Loudon KW, Wlodek E, et al. Renal Sodium Gradient Orchestrates a Dynamic Antibacterial Defense Zone. Cell. 2017;170(5):860–74 e19. Epub 2017/08/15. 10.1016/j.cell.2017.07.022 . [DOI] [PubMed] [Google Scholar]
  • 10.Neubert P, Weichselbaum A, Reitinger C, Schatz V, Schroder A, Ferdinand JR, et al. HIF1A and NFAT5 coordinate Na(+)-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting. Autophagy. 2019:1–18. Epub 2019/04/16. 10.1080/15548627.2019.1596483 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Binger KJ, Gebhardt M, Heinig M, Rintisch C, Schroeder A, Neuhofer W, et al. High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest. 2015;125(11):4223–38. Epub 2015/10/21. 10.1172/JCI80919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ip WK, Medzhitov R. Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation. Nat Commun. 2015;6:6931 Epub 2015/05/12. 10.1038/ncomms7931 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhang WC, Zheng XJ, Du LJ, Sun JY, Shen ZX, Shi C, et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res. 2015;25(8):893–910. Epub 2015/07/25. 10.1038/cr.2015.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhang WC, Du LJ, Zheng XJ, Chen XQ, Shi C, Chen BY, et al. Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance. J Biol Chem. 2018;293(3):1030–9. Epub 2017/12/06. 10.1074/jbc.M117.805093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hucke S, Eschborn M, Liebmann M, Herold M, Freise N, Engbers A, et al. Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. J Autoimmun. 2016;67:90–101. Epub 2015/11/21. 10.1016/j.jaut.2015.11.001 . [DOI] [PubMed] [Google Scholar]
  • 16.Heng TS, Painter MW. The Immunological Genome Project: networks of gene expression in immune cells. Nature immunology. 2008;9(10):1091–4. Epub 2008/09/19. 10.1038/ni1008-1091 . [DOI] [PubMed] [Google Scholar]
  • 17.Iwamoto T, Watano T, Shigekawa M. A Novel Isothiourea Derivative Selectively Inhibits the Reverse Mode of Na+/Ca2+ Exchange in Cells Expressing NCX1. Journal of Biological Chemistry. 1996;271(37):22391–7. 10.1074/jbc.271.37.22391 [DOI] [PubMed] [Google Scholar]
  • 18.Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, et al. SEA0400, a Novel and Selective Inhibitor of the Na+-Ca2+ Exchanger, Attenuates Reperfusion Injury in the in Vitro and in Vivo Cerebral Ischemic Models. Journal of Pharmacology and Experimental Therapeutics. 2001;298(1):249–56. [PubMed] [Google Scholar]
  • 19.Kimura J, Miyamae S, Noma A. Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig. J Physiol. 1987;384:199–222. 10.1113/jphysiol.1987.sp016450 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Donnadieu E, Trautmann A. Is there a Na+/Ca2+ exchanger in macrophages and in lymphocytes? Pflugers Arch. 1993;424(5–6):448–55. Epub 1993/09/01. 10.1007/BF00374907 . [DOI] [PubMed] [Google Scholar]
  • 21.Staiano RI, Granata F, Secondo A, Petraroli A, Loffredo S, Frattini A, et al. Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes. Eur J Immunol. 2009;39(5):1405–18. Epub 2009/04/08. 10.1002/eji.200838792 . [DOI] [PubMed] [Google Scholar]
  • 22.Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev. 1999;79(3):763–854. Epub 1999/07/03. 10.1152/physrev.1999.79.3.763 . [DOI] [PubMed] [Google Scholar]
  • 23.Gerth A, Grosche J, Nieber K, Hauschildt S. Intracellular LPS inhibits the activity of potassium channels and fails to activate NFkappaB in human macrophages. J Cell Physiol. 2005;202(2):442–52. Epub 2004/09/25. 10.1002/jcp.20146 . [DOI] [PubMed] [Google Scholar]
  • 24.Ypey DL, Clapham DE. Development of a delayed outward-rectifying K+ conductance in cultured mouse peritoneal macrophages. Proc Natl Acad Sci U S A. 1984;81(10):3083–7. Epub 1984/05/01. 10.1073/pnas.81.10.3083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Baartscheer A, Schumacher CA, Coronel R, Fiolet JW. The Driving Force of the Na/Ca-Exchanger during Metabolic Inhibition. Front Physiol. 2011;2:10 10.3389/fphys.2011.00010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Young JD, Unkeless JC, Kaback HR, Cohn ZA. Macrophage membrane potential changes associated with gamma 2b/gamma 1 Fc receptor-ligand binding. Proc Natl Acad Sci U S A. 1983;80(5):1357–61. Epub 1983/03/01. 10.1073/pnas.80.5.1357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gallin EK, Gallin JI. Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes. J Cell Biol. 1977;75(1):277–89. Epub 1977/10/01. 10.1083/jcb.75.1.277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gallin EK, Livengood DR. Nonlinear current-voltage relationships in cultured macrophages. J Cell Biol. 1980;85(1):160–5. Epub 1980/04/01. 10.1083/jcb.85.1.160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hanley PJ, Musset B, Renigunta V, Limberg SH, Dalpke AH, Sus R, et al. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad Sci U S A. 2004;101(25):9479–84. Epub 2004/06/15. 10.1073/pnas.0400733101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, et al. Macrophages Facilitate Electrical Conduction in the Heart. Cell. 2017;169(3):510–22 e20. Epub 2017/04/22. 10.1016/j.cell.2017.03.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Philipson KD, Nicoll DA. Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol. 2000;62:111–33. Epub 2000/06/09. 10.1146/annurev.physiol.62.1.111 . [DOI] [PubMed] [Google Scholar]
  • 32.Masek KS, Fiore J, Leitges M, Yan SF, Freedman BD, Hunter CA. Host cell Ca2+ and protein kinase C regulate innate recognition of Toxoplasma gondii. J Cell Sci. 2006;119(Pt 21):4565–73. Epub 2006/11/01. 10.1242/jcs.03206 . [DOI] [PubMed] [Google Scholar]
  • 33.Shinomiya H, Nakano M. Calcium ionophore A23187 does not stimulate lipopolysaccharide nonresponsive C3H/HeJ peritoneal macrophages to produce interleukin 1. J Immunol. 1987;139(8):2730–6. Epub 1987/10/15. PubMed . [PubMed] [Google Scholar]
  • 34.Vaeth M, Zee I, Concepcion AR, Maus M, Shaw P, Portal-Celhay C, et al. Ca2+ Signaling but Not Store-Operated Ca2+ Entry Is Required for the Function of Macrophages and Dendritic Cells. J Immunol. 2015;195(3):1202–17. 10.4049/jimmunol.1403013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Treiman M, Caspersen C, Christensen SB. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci. 1998;19(4):131–5. 10.1016/s0165-6147(98)01184-5 . [DOI] [PubMed] [Google Scholar]
  • 36.Amran MS, Homma N, Hashimoto K. Pharmacology of KB-R7943: a Na+-Ca2+ exchange inhibitor. Cardiovasc Drug Rev. 2003;21(4):255–76. Epub 2003/12/04. 10.1111/j.1527-3466.2003.tb00121.x . [DOI] [PubMed] [Google Scholar]
  • 37.Kimura S, Noda T, Yoshimori T. Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3. Autophagy. 2007;3(5):452–60. 10.4161/auto.4451 [DOI] [PubMed] [Google Scholar]
  • 38.Muller DN, Wilck N, Haase S, Kleinewietfeld M, Linker RA. Sodium in the microenvironment regulates immune responses and tissue homeostasis. Nat Rev Immunol. 2019;19(4):243–54. Epub 2019/01/16. 10.1038/s41577-018-0113-4 . [DOI] [PubMed] [Google Scholar]
  • 39.Schatz V, Neubert P, Schroder A, Binger K, Gebhard M, Muller DN, et al. Elementary immunology: Na(+) as a regulator of immunity. Pediatr Nephrol. 2017;32(2):201–10. Epub 2016/02/28. 10.1007/s00467-016-3349-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gurusamy D, Clever D, Eil R, Restifo NP. Novel "Elements" of Immune Suppression within the Tumor Microenvironment. Cancer Immunol Res. 2017;5(6):426–33. 10.1158/2326-6066.CIR-17-0117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265(5173):808–11. Epub 1994/08/05. 10.1126/science.7914033 . [DOI] [PubMed] [Google Scholar]
  • 42.Lopez-Rodriguez C, Aramburu J, Rakeman AS, Rao A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci U S A. 1999;96(13):7214–9. Epub 1999/06/23. 10.1073/pnas.96.13.7214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(5):2538–42. 10.1073/pnas.96.5.2538 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ko BCB, Turck CW, Lee KWY, Yang Y, Chung SSM. Purification, Identification, and Characterization of an Osmotic Response Element Binding Protein. Biochemical and Biophysical Research Communications. 2000;270(1):52–61. 10.1006/bbrc.2000.2376 [DOI] [PubMed] [Google Scholar]
  • 45.West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472(7344):476–80. Epub 2011/04/29. 10.1038/nature09973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Black JA, Waxman SG. Noncanonical roles of voltage-gated sodium channels. Neuron. 2013;80(2):280–91. Epub 2013/10/22. 10.1016/j.neuron.2013.09.012 . [DOI] [PubMed] [Google Scholar]
  • 47.Barbaro NR, Foss JD, Kryshtal DO, Tsyba N, Kumaresan S, Xiao L, et al. Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension. Cell Rep. 2017;21(4):1009–20. Epub 2017/10/27. 10.1016/j.celrep.2017.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev. 2009;231(1):59–87. Epub 2009/09/17. 10.1111/j.1600-065X.2009.00816.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, Prince AS, et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature. 2014;506(7489):503–6. Epub 2014/01/28. 10.1038/nature12902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Nurbaeva MK, Schmid E, Szteyn K, Yang W, Viollet B, Shumilina E, et al. Enhanced Ca(2)(+) entry and Na+/Ca(2)(+) exchanger activity in dendritic cells from AMP-activated protein kinase-deficient mice. FASEB J. 2012;26(7):3049–58. 10.1096/fj.12-204024 . [DOI] [PubMed] [Google Scholar]
  • 51.Decuypere JP, Bultynck G, Parys JB. A dual role for Ca(2+) in autophagy regulation. Cell Calcium. 2011;50(3):242–50. Epub 2011/05/17. 10.1016/j.ceca.2011.04.001 . [DOI] [PubMed] [Google Scholar]
  • 52.Kondratskyi A, Kondratska K, Skryma R, Klionsky DJ, Prevarskaya N. Ion channels in the regulation of autophagy. Autophagy. 2018;14(1):3–21. Epub 2017/10/06. 10.1080/15548627.2017.1384887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Freeman SA, Uderhardt S, Saric A, Collins RF, Buckley CM, Mylvaganam S, et al. Lipid-gated monovalent ion fluxes regulate endocytic traffic and support immune surveillance. Science. 2020;367(6475):301–5. 10.1126/science.aaw9544 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Bentley PJ. Amiloride: a potent inhibitor of sodium transport across the toad bladder. J Physiol. 1968;195(2):317–30. 10.1113/jphysiol.1968.sp008460 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Vigne P, Frelin C, Cragoe EJ, Lazdunski M. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system. Molecular Pharmacology. 1984;25(1):131–6. [PubMed] [Google Scholar]
  • 56.Thorneloe KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian M-Y, et al. An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure. Science Translational Medicine. 2012;4(159):159ra48–ra48. 10.1126/scitranslmed.3004276 [DOI] [PubMed] [Google Scholar]
  • 57.Takata M, Moore JW, Kao CY, Fuhrman FA. Blockage of sodium conductance increase in lobster giant axon by tarichatoxin (tetrodotoxin). J Gen Physiol. 1966;49(5):977–88. 10.1085/jgp.49.5.977 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hoffman JF, Kregenow FM. The Characterization of New Energy Dependent Cation Transport Processes in Red Blood Cells. Annals of the New York Academy of Sciences. 1966;137(2):566–76. 10.1111/j.1749-6632.1966.tb50182.x [DOI] [PubMed] [Google Scholar]
  • 59.Chen X, Qiu L, Li M, Dürrnagel S, Orser BA, Xiong Z-G, et al. Diarylamidines: high potency inhibitors of acid-sensing ion channels. Neuropharmacology. 2010;58(7):1045–53. Epub 2010/01/28. 10.1016/j.neuropharm.2010.01.011 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Schleicher U, Bogdan C. Generation, culture and flow-cytometric characterization of primary mouse macrophages. Methods Mol Biol. 2009;531:203–24. Epub 2009/04/07. 10.1007/978-1-59745-396-7_14 . [DOI] [PubMed] [Google Scholar]
  • 61.Siegert I, Schatz V, Prechtel AT, Steinkasserer A, Bogdan C, Jantsch J. Electroporation of siRNA into Mouse Bone Marrow-Derived Macrophages and Dendritic Cells In: Li S, Cutrera J, Heller R, Teissie J, editors. Electroporation Protocols: Preclinical and Clinical Gene Medicine. New York, NY: Springer New York; 2014. p. 111–9. [DOI] [PubMed] [Google Scholar]
  • 62.Mustroph J, Wagemann O, Lücht CM, Trum M, Hammer KP, Sag CM, et al. Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes. ESC heart failure. 2018;5(4):642–8. 10.1002/ehf2.12336 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.June CH, Abe R, Rabinovitch PS. Measurement of Intracellular Ions by Flow Cytometry. Current Protocols in Immunology. 1995;14(1):5–21. 10.1002/0471142735.im0505s14 [DOI] [PubMed] [Google Scholar]
  • 64.Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391(2):85–100. Epub 1981/08/01. 10.1007/BF00656997 . [DOI] [PubMed] [Google Scholar]
  • 65.Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11(9):1650–67. Epub 2016/08/26. 10.1038/nprot.2016.095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Frazee AC, Pertea G, Jaffe AE, Langmead B, Salzberg SL, Leek JT. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat Biotechnol. 2015;33(3):243–6. Epub 2015/03/10. 10.1038/nbt.3172 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Inhibitor data.

List of used inhibitors and concentrations.

(DOCX)

S1 Fig. Effects of NCX inhibitors on NO production.

NO production was quantified 24 h after incubation of RAW264.7 MΦs ± HS ± after pretreatment with indicated inhibitor. (A) Inhibitor KB-R (n = 9). (B) Inhibitor NiCl2 (n = 6). (C) Inhibitor SEA (n = 6). For numerical raw data, please see S1 Data. HS, high salt; MΦ, monocyte/macrophage-like cell; KB-R, KB-R7943 mesylate; NCX, Na+/Ca2+ exchanger; NO, nitric oxide; SEA, SEA 0400.

(TIF)

S2 Fig. Current clamp measurements of MΦ upon LPS stimulation.

Vm of BMDMs before and after addition of 10 ng/ml LPS (n = 8; paired t test; *p < 0.05). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; Vm, membrane potential.

(TIF)

S3 Fig. Effects on selected NCX inhibitors on MΦ viability.

RAW264.7 MΦs were pretreated with indicated NCX inhibitors. At 4 h after stimulation ± LPS ± HS relative LDH release normalized to total cellular LDH content was assessed. Exposure of cells to 0.1% Triton X was used as positive control for cytotoxicity (means ± SD; n = 9). For numerical raw data, please see S1 Data. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger.

(TIF)

S4 Fig. Effects of NCX inhibitors on NFAT5 accumulation.

(A) NFAT5 levels 6 h after incubation of RAW264.7 MΦs ± HS ± KB-R pretreatment. Immunoblotting and densitometry (n = 4; paired t tests; *p < 0.05). (B) NFAT5 levels 4 h after incubation of RAW264.7 MΦs ± HS ± NiCl2 pretreatment. Immunoblotting and densitometry (n = 4; paired t tests; *p < 0.05). (C) As in (B), but SEA was used to inhibit NCX (n = 7; paired t tests; *p < 0.05). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. HS, high salt; KB-R, KB-R7943 mesylate; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; NFAT5, nuclear factor of activated T cells 5; SEA, SEA 0400.

(TIF)

S5 Fig. Slc8a1 silencing reduces Slc8a1 mRNA levels.

Slc8a1 expression in ns or Slc8a1-specific siRNA–treated BMDMs (means ± SD; n = 8; Student t test; *p < 0.05). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8.

(TIF)

S6 Fig. Slc8a1 silencing diminishes inward currents upon HS treatment.

Current/voltage relationships of BMDMs treated with ns siRNA and Slc8a1 siRNA. These MΦ were stimulated with HS followed by NiCl2 treatment. Whole-cell VR experiments were performed, and Ni-sensitive (i.e., NCX-sensitive) currents were determined (means ± 95% CI; n = 9–10). For numerical raw data, please see S1 Data. BMDM, bone marrow–derived MΦ; HS, high salt; MΦ, monocyte/macrophage-like cell; NCX, Na+/Ca2+ exchanger; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8; VR, voltage ramp.

(TIF)

S7 Fig. Slc8a1 silencing reduces HS-augmented NFAT5 accumulation.

(A) NFAT5 expression 4 h after LPS ± HS in ns siRNA and Slc8a1 siRNA–treated RAW264.7 MΦs. Representative NFAT5 and ACTIN immunoblot out of two similar experiments. (B) As in (A), but HS-triggered Δ nitrite after 24 h (n = 3). For numerical raw data, please see S1 Data. For raw immunoblots, please see S1 Blots. HS, high salt; LPS, lipopolysaccharide; MΦ, monocyte/macrophage-like cell; NFAT5, nuclear factor of activated T cells 5; ns, nonsilencing; siRNA, small interfering RNA; Slc8, solute carrier family 8.

(TIF)

S1 Data. Numerical raw data.

All numerical raw data are combined in a single Excel file “S1_Data.xlsx”. This file consists of several spreadsheets. Each spreadsheet contains the raw data of one subfigure.

(XLSX)

S1 Blots. Raw images.

The file “S1_Blots.pdf” covers all uncropped western blot images, including size standards and descriptions.

(PDF)

Data Availability Statement

All relevant data are within the paper and its supporting information files (S1 Data, S1 Blots). The RNA-seq data was deposited in the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov). The accession number is GSE136662.


Articles from PLoS Biology are provided here courtesy of PLOS

RESOURCES